Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3 in Kenya was reported at 41.1 % in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources. Kenya - Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3 - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
 kenya anti malarial drug use by pregnant women sp fansidar two or more doses percent of women with a birth q3 wb data


Anti-malarial drug use by pregnant women: Percentage of women with a live birth in the two years preceding the survey who during the pregnancy took any antimalarial drug for prevention, and who took SP/Fansidar two or more doses.


Kenya | World Bank Development Indicators